- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
85
Companies with a Value score of at least 3, ordered by Value score
85 companies
Grand Pharmaceutical Group
Market Cap: HK$20.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.91
7D
-6.6%
1Y
44.1%
Grand Pharmaceutical Group
Market Cap: HK$20.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.91
7D
-6.6%
1Y
44.1%
Grand Pharmaceutical Group
Market Cap: HK$20.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.80
7D
3.8%
1Y
45.4%
Shanghai Haohai Biological Technology
Market Cap: HK$12.3b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.35
7D
-11.1%
1Y
-12.1%
BeiGene
Market Cap: HK$24.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$148.10
7D
17.8%
1Y
76.3%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.59
7D
3.7%
1Y
-19.1%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.59
7D
3.7%
1Y
-19.1%
3SBio
Market Cap: HK$29.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.86
7D
27.1%
1Y
118.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.7b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.95
7D
8.9%
1Y
-54.9%
Innovent Biologics
Market Cap: HK$78.2b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$48.40
7D
22.1%
1Y
35.0%
Consun Pharmaceutical Group
Market Cap: HK$7.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.76
7D
15.9%
1Y
72.4%
United Laboratories International Holdings
Market Cap: HK$22.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$12.50
7D
-12.0%
1Y
28.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.7b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.93
7D
-3.0%
1Y
-55.4%
WuXi AppTec
Market Cap: HK$149.0b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$51.30
7D
-20.0%
1Y
46.2%
Shanghai Haohai Biological Technology
Market Cap: HK$12.3b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.35
7D
-11.1%
1Y
-12.1%
JW (Cayman) Therapeutics
Market Cap: HK$598.8m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.52
7D
16.9%
1Y
-14.6%
United Laboratories International Holdings
Market Cap: HK$22.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$12.50
7D
-12.0%
1Y
28.6%
Innovent Biologics
Market Cap: HK$78.2b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$47.75
7D
-5.0%
1Y
27.8%
3SBio
Market Cap: HK$29.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.40
7D
-6.1%
1Y
108.4%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.7b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.93
7D
-3.0%
1Y
-55.4%
Innovent Biologics
Market Cap: HK$78.2b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$47.75
7D
-5.0%
1Y
27.8%
China Shineway Pharmaceutical Group
Market Cap: HK$5.7b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.76
7D
6.0%
1Y
-17.3%
WuXi AppTec
Market Cap: HK$149.0b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$52.95
7D
3.8%
1Y
55.3%
China Medical System Holdings
Market Cap: HK$17.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.23
7D
-12.7%
1Y
-0.3%
3SBio
Market Cap: HK$29.2b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.40
7D
-6.1%
1Y
108.4%
China Medical System Holdings
Market Cap: HK$17.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.23
7D
-12.7%
1Y
-0.3%
WuXi AppTec
Market Cap: HK$149.0b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$51.30
7D
-20.0%
1Y
46.2%
BeiGene
Market Cap: HK$24.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$136.70
7D
8.8%
1Y
62.7%
BeiGene
Market Cap: HK$24.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$136.70
7D
8.8%
1Y
62.7%
United Laboratories International Holdings
Market Cap: HK$22.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$13.32
7D
18.5%
1Y
35.6%
China Medical System Holdings
Market Cap: HK$17.5b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.53
7D
5.3%
1Y
5.3%
Zai Lab
Market Cap: HK$3.2b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$22.20
7D
-22.9%
1Y
92.4%
CanSino Biologics
Market Cap: HK$10.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$29.70
7D
14.5%
1Y
70.7%
PuraPharm
Market Cap: HK$195.6m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.49
7D
-2.0%
1Y
-38.0%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$941.2m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.69
7D
9.0%
1Y
-6.6%
Sanai Health Industry Group
Market Cap: HK$47.4m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.30
7D
-1.6%
1Y
-57.9%